Suppr超能文献

kratom的复杂性:关于日益频繁的临床接触的见解

The Complexities of Kratom: Insights on an Increasingly Frequent Clinical Encounter.

作者信息

Alghalith Adam, Nguyen Hoanglong, Tennant Richard

机构信息

Psychiatry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA.

Internal Medicine, Olive View-University of California Los Angeles Medical Center, Los Angeles, USA.

出版信息

Cureus. 2024 May 4;16(5):e59650. doi: 10.7759/cureus.59650. eCollection 2024 May.

Abstract

(kratom) is a tropical tree native to Southeast Asia with dose-dependent stimulant and opioid properties. Kratom has garnered attention due to its increasing popularity and potential for dependence, tolerance, and withdrawal. We report the case of a 72-year-old man admitted to the hospital for a deep vein thrombosis and obstructive uropathy who began experiencing kratom withdrawal. He experienced less cravings and improvement in withdrawal symptoms with buprenorphine-naloxone 8 mg/2 mg daily. Notably, our case highlights kratom's contributions to a medically complex presentation and potential kratom-drug interactions due to its posited inhibitory effect on cytochrome P450 enzymes and P-glycoprotein. Our case adds to the growing literature which describes buprenorphine-naloxone as an effective treatment for kratom dependence and withdrawal.

摘要

(kratom)是一种原产于东南亚的热带树木,具有剂量依赖性的兴奋和阿片样物质特性。由于其日益普及以及存在依赖、耐受和戒断的可能性,kratom已引起关注。我们报告了一名72岁男性因深静脉血栓形成和梗阻性尿路病入院,他开始出现kratom戒断症状。他每天服用8毫克/2毫克的丁丙诺啡-纳洛酮后,渴望程度降低,戒断症状有所改善。值得注意的是,我们的病例突出了kratom对复杂医学表现的影响,以及由于其对细胞色素P450酶和P-糖蛋白的假定抑制作用而可能产生的kratom-药物相互作用。我们的病例补充了越来越多将丁丙诺啡-纳洛酮描述为治疗kratom依赖和戒断的有效方法的文献。

相似文献

1
The Complexities of Kratom: Insights on an Increasingly Frequent Clinical Encounter.
Cureus. 2024 May 4;16(5):e59650. doi: 10.7759/cureus.59650. eCollection 2024 May.
2
A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management.
J Psychoactive Drugs. 2020 Nov-Dec;52(5):447-452. doi: 10.1080/02791072.2020.1773586. Epub 2020 Jun 17.
3
Buprenorphine-Naloxone in the Setting of Kratom Withdrawal, Opioid Use Disorder, and Stage IV Lung Adenocarcinoma.
J Palliat Med. 2023 May;26(5):734-736. doi: 10.1089/jpm.2022.0491. Epub 2022 Dec 29.
4
Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa).
J Clin Pharmacol. 2022 May;62(5):577-593. doi: 10.1002/jcph.2001. Epub 2022 Jan 5.
5
Management of kratom dependence with buprenorphine/naloxone in a veteran population.
Subst Abus. 2021;42(4):497-502. doi: 10.1080/08897077.2021.1878086. Epub 2021 Feb 22.
6
Non-Prescribed Buprenorphine Use Mediates the Relationship between Heroin Use and Kratom Use among a Sample of Polysubstance Users.
J Psychoactive Drugs. 2019 Sep-Oct;51(4):311-322. doi: 10.1080/02791072.2019.1597224. Epub 2019 Apr 8.
7
Home induction and outpatient treatment of kratom use disorder with buprenorphine-naloxone: A case report in a young adult.
Subst Abus. 2020;41(3):311-314. doi: 10.1080/08897077.2019.1671945. Epub 2019 Oct 23.
8
Use of Kratom, an Opioid-like Traditional Herb, in Pregnancy.
Obstet Gynecol. 2018 Oct;132(4):926-928. doi: 10.1097/AOG.0000000000002871.
9
Kratom Dependence and Treatment Options: A Comprehensive Review of the Literature.
Curr Drug Targets. 2020;21(15):1566-1579. doi: 10.2174/1389450121666200719011653.
10
Exploring the self-reported motivations of kratom ( Korth.) use: a cross-sectional investigation.
Am J Drug Alcohol Abuse. 2022 Jul 4;48(4):433-444. doi: 10.1080/00952990.2022.2041026. Epub 2022 Apr 7.

本文引用的文献

1
Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom.
Clin Pharmacol Ther. 2023 Jun;113(6):1315-1325. doi: 10.1002/cpt.2891. Epub 2023 Mar 28.
2
High-Dose Buprenorphine Initiation in the Emergency Department Among Patients Using Fentanyl and Other Opioids.
JAMA Netw Open. 2023 Mar 1;6(3):e231572. doi: 10.1001/jamanetworkopen.2023.1572.
3
Long-term buprenorphine treatment for kratom use disorder: A case series.
Subst Abus. 2022;43(1):763-766. doi: 10.1080/08897077.2021.2010250.
6
Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study.
Addiction. 2021 Jan;116(1):176-181. doi: 10.1111/add.15082. Epub 2020 Apr 28.
7
Notes from the Field: Unintentional Drug Overdose Deaths with Kratom Detected - 27 States, July 2016-December 2017.
MMWR Morb Mortal Wkly Rep. 2019 Apr 12;68(14):326-327. doi: 10.15585/mmwr.mm6814a2.
8
Kratom exposures reported to United States poison control centers: 2011-2017.
Clin Toxicol (Phila). 2019 Oct;57(10):847-854. doi: 10.1080/15563650.2019.1569236. Epub 2019 Feb 20.
9
Deaths in Colorado Attributed to Kratom.
N Engl J Med. 2019 Jan 3;380(1):97-98. doi: 10.1056/NEJMc1811055.
10
Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.
Forensic Sci Med Pathol. 2019 Mar;15(1):110-113. doi: 10.1007/s12024-018-0049-9. Epub 2018 Nov 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验